利索-全球专利检索

  1. 登录
  2. 注册
发明申请
US20100197502A1 Crystalline form of [3-(4,5-dihydro-3-isoxazolyl)-2-methyl-4-(methylsulfonyl)phenyl]-(5-hydroxy-1-methyl-1H-pyrazol-4-yl)methanone 有权
[3-（4,5-二氢-3-异恶唑基）-2-甲基-4-（甲基磺酰基）苯基] - （5-羟基-1-甲基-1H-吡唑-4-基）甲酮的结晶形式

Crystalline form of [3-(4,5-dihydro-3-isoxazolyl)-2-methyl-4-(methylsulfonyl)phenyl]-(5-hydroxy-1-methyl-1H-pyrazol-4-yl)methanone
摘要：
The present invention relates to crystalline forms of [3-(4,5-dihydro-3-isoxazolyl)-2-methyl-4-(methylsulfonyl)phenyl]-(5-hydroxy-1-methyl-1 H-pyrazol-4-yl)methanone, which is also known under the common name topramezone. The invention also relates to a process for the preparation of these crystalline forms and formulations for plant protection which comprise one of these crystalline forms of topramezone.
摘要（中）：

本发明涉及[3-（4,5-二氢-3-异恶唑基）-2-甲基-4-（甲基磺酰基）苯基] - （5-羟基-1-甲基-1H-吡唑-4-基） 甲基）甲酮，其也称为topramezone。 本发明还涉及一种制备这些结晶形式的方法和用于植物保护的制剂，其包含这些topramezone结晶形式之一。

公开/授权文献
信息查询
Global Dossier Espacenet
0/0